RhAPPcast

RhAPPcast

Por: Rheumatology Advanced Practice Providers (RhAPP)
This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). 
 
Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 
142 episodios disponibles

Latest episodes of the podcast RhAPPcast

FAQ: What is Hypophosphatasia and How Does It Present Across the Lifespan? 15/01/2026
Journal Club: Guselkumab Binds To CD64+ IL-23–Producing Myeloid Cells to Neutralize IL-23 Signals 13/01/2026
FAQ: How Is Hypophosphatasia Diagnosed and What Are the Key Laboratory Markers? 08/01/2026
What Is the Correlation of CD64 and IL-23 Expression in Inflamed Joint, Skin, and Gut Tissue? 06/01/2026
FAQ: What is the Normal Role of CD64 in Innate and Adaptive Immunity? 23/12/2025
Podcast: A Tale of Two Pediatric APPs 19/12/2025
Medication Review: Describe the Dual Mechanism of Action of Guselkumab 16/12/2025
FAQ: Why is the mvdH-S Score Used Most Often in PsA Trials? 11/12/2025
FAQ: How Does The Design of APEX Differ From DISCOVER-2 To Enrich For Structural Damage? 09/12/2025
The Conversation That Matters: Talking to Patients About Obesity and IMIDs 01/12/2025
From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs 24/11/2025
The Hidden Costs: Obesity’s Role in Suboptimal Outcomes and Healthcare Burden in IMIDs 17/11/2025
Obesity and IMIDs: Unpacking the Epidemic and Its Far-Reaching Impacts 10/11/2025
Live from RhAPP National: ILD & PH-ILD at the Rheum–Pulm Crossroads 06/11/2025
RhAPPcast: ANCA-Associated Vasculitis: Insights From the RhAPP National Conference 03/11/2025
FAQ: What is the clinical significance of structural damage in PsA? 30/10/2025
Medication Review: Evidence for Guselkumab in Preventing Structural Damage Progression 28/10/2025
RhAPPcast: Beyond Dryness: Key Takeaways from the Sjögren’s Symposium at RhAPP 2025 21/10/2025
FAQ: What is the Effect of Guselkumab on Structural Damage in PsA? 16/10/2025
FAQ: What is the Inflation Reduction Act & How Does It Impact Affordability of Biologic Therapies? 14/10/2025
1 2 3 ... 8 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA